Vedio-assisted Thoracoscopic Lobectomy vs Open Lobectomy for Patients With Surgically Resectable Pathologic N2 NSCLC

Tang-Du Hospital10 sites in 1 country2,145 target enrollmentJuly 4, 2018

ConditionsNon-small Cell Lung Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Non-small Cell Lung Cancer
Sponsor: Tang-Du Hospital
Enrollment: 2145
Locations: 10
Primary Endpoint: Overall survival
Status: Completed
Last Updated: 7 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The study was designed to compare the safety and effectiveness of vedio-assisted thoracoscopic lobectomy with open lobectomy for patients with surgically resectable pathologic N2 non-small cell lung cancer

Detailed Description

The is a multi-center retrospective study. Patients with pathologic N2 NSCLC who underwent VATS or open lobectomy between 2014 and 2017 were included into this study. Clinical data on patient demographic, clinical characteristics, treatment and clinical outcomes will be collected to evaluate the safety and effectiveness of video-assisted thoracoscopic lobectomy for pathologic N2 NSCLC.

Registry

clinicaltrials.gov

Start Date

July 4, 2018

End Date

July 6, 2018

Last Updated

7 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Tang-Du Hospital

Responsible Party

Principal Investigator

lixiaofei

Professor

Tang-Du Hospital

Eligibility Criteria

Inclusion Criteria

•Patients with age \> 18 years old;
•Patients with pathologically diagnosed non-small cell lung cancer;
•Patients underwent lobectomy by either VATS or thoracotomy between 2014 and 2017;
•Patients who received lymphadenectomy for all accessible lymph nodes;
•Patients with N2 lymph nodes (+) after surgeries;